Transfected Stable Cell Lines
Reliable | High-Performance | Wide Rage
Precision reporter, kinase, immune receptor, biosimilar, Cas9, and knockout stable cell lines for diverse applications.
Cat. No. : CSC-RO0237
Host Cell : Ba/F3 Size : >1x106 frozen cells/vial
| Cat. No. | CSC-RO0237 |
| Description | This cell line is engineered to stably express human FLT3 gene. |
| Target Gene | FLT3 |
| Gene Species | Homo sapiens (Human) |
| Host Cell | Ba/F3 |
| Host Cell Species | Mus musculus (Mouse) |
| Applications | Drug screening and biological assays |
| Biosafety Level | 2 |
| Size | >1x10^6 frozen cells/vial, 1 mL |
| Stability | Stable in culture over a minimum of 10 passages |
| Quality Control | Negative for bacteria, yeast, fungi and mycoplasma. |
| Growth Conditions | 37 °C, 5% CO2 |
| Storage | Liquid nitrogen |
| Shipping | Dry ice |
| Thawing & Subculturing Instructions | 1. Thaw cells by gently swirling in a 37°C water bath. To limit contamination, do not submerge the O-ring and cap. 2. When cells are ~70% thawed (~1 min), transfer the vial into a biosafety cabinet, and wipe the surface with 70% ethanol. Allow tube to dry completely. 3. Transfer the cells gently into a 15 mL conical tube containing 10 mL of pre-warmed culture medium (without antibiotic selection marker). Centrifuge cells at ~125 x g for 5~7 min. 4. Remove supernatant without disturbing the pellet, and resuspend cells in 1 mL culture medium (without antibiotic selection marker). Transfer cells to a 6-well plate containing ~2 mL pre-warmed growth medium (without antibiotic selection marker) or a T25 flask containing 5 mL pre-warmed culture medium (without antibiotic selection marker). 5. Incubate the culture at 37°C with 5% CO2. 6. Subculture: split saturated culture 1:4 ~ 1:6 every 3 days; seed out at about 1~3 x 10^5 cells/mL. |
| Freeze Medium | Frozen with 70% medium, 20% FBS, 10% DMSO |
| Growth Properties | Suspension, round |
| Freezing Instructions | Cells are recommended to generate additional frozen stocks at early passages. Frozen stocks should be preserved in a designated cryopreservation medium or in 70% RPMI 1640 + 20% FBS + 10% DMSO (without antibiotic selection marker). 1. Prepare the freezing medium (70% RPMI 1640 + 20% FBS + 10% DMSO, without antibiotic selection marker) fresh immediately before use. 2. Keep the freezing medium on ice and label cryovials. 3. Transfer cells to a sterile, conical centrifuge tube, and count the cells. 4. Centrifuge the cells at 250 x g for 5 minutes at room temperature and carefully aspirate off the medium. 5. Resuspend the cells at a density of at least 3 x10^6 cells/ml in chilled freezing medium. 6. Aliquot 1 ml of the cell suspension into each cryovial. 7. Freeze cells in the CoolCell freezing container overnight in a -80°C freezer. 8. Transfer vials to liquid nitrogen for long-term storage. |
| Mycoplasma | Negative |
| Format | One frozen vial containing millions of cells |
| Storage | Liquid nitrogen |
| Safety Considerations |
The following safety precautions should be observed. 1. Use pipette aids to prevent ingestion and keep aerosols down to a minimum. 2. No eating, drinking or smoking while handling the stable line. 3. Wash hands after handling the stable line and before leaving the lab. 4. Decontaminate work surface with disinfectant or 70% ethanol before and after working with stable cells. 5. All waste should be considered hazardous. 6. Dispose of all liquid waste after each experiment and treat with bleach. |
| Ship | Dry ice |
| Gene Name | FLT3 fms-related tyrosine kinase 3 [ Homo sapiens ] |
| Gene Symbol | FLT3 |
| Synonyms | FLK2; STK1; CD135; FLK-2 |
| Gene Description | fms-related tyrosine kinase 3 |
| GeneID | 2322 |
| Uni ProtID | P36888 |
| mRNA Refseq | NM_004119.2 |
| Protein Refseq | NP_004110.2 |
| Chromosome Location | 13q12 |
| Function | ATP binding; cytokine receptor activity; phosphatidylinositol 3-kinase binding; protein binding; protein homodimerization activity; transmembrane receptor protein tyrosine kinase activity; vascular endothelial growth factor-activated receptor activity; |
| Pathway | Acute myeloid leukemia, organism-specific biosystem; Acute myeloid leukemia, conserved biosystem; Cytokine-cytokine receptor interaction, organism-specific biosystem; Cytokine-cytokine receptor interaction, conserved biosystem; Hematopoietic cell lineage, organism-specific biosystem; Hematopoietic cell lineage, conserved biosystem; Pathways in cancer, organism-specific biosystem; |
| MIM | 136351 |
FLT3 (or FMS-related tyrosine kinase 3) is a protein that is critical for the maturation of hematopoietic progenitor cells (cells that eventually develop into blood cells). FLT3 plays a crucial role in cell development, particularly in the production and development of blood cells in the bone marrow. In a healthy body, the FLT3 gene helps control how quickly and how many cells the body produces. However, mutations in the FLT3 gene can lead to the overproduction of immature blood cells, a condition that can lead to acute myeloid leukemia (AML). Due to its association with cancer, FLT3 has become an important area of research in cancer research. There are currently several therapies and drugs that target FLT3 in development with the goal of treating or preventing leukemia and other similar diseases.
Human FLT3 Stable Cell Line-Ba/F3 is engineered to stably integrate the human FLT3 gene into Ba/F3 cells. This specific feature of the human FLT3 stable cell line-Ba/F3 is particularly useful for the study of AML, as well as drug screening studies to identify potential therapeutic targets in this process. This cell line provides researchers with an important tool to understand the function of FLT3 and the effects of mutations.
The human FLT3 stable cell line-Ba/F3 is widely used in biomedical research, more specifically in the field of cancer research. Here are a few key points of its application:
Drug screening: This cell line is commonly used to screen new drugs and small molecules targeting FLT3. This cell line expresses large amounts of FLT3 protein, making it an ideal model for studying the efficacy of drugs against FLT3 mutant cells.
Molecular biology studies: This cell line is used to study the molecular biology of the FLT3 protein, specifically its mutation status.
Cancer research: FLT3 mutations associated with acute myeloid leukemia (AML). The Ba/F3 cell line expressing human FLT3 was used to study the role of this protein in the pathogenesis of AML, which could lead to the development of new therapeutic strategies for this disease.
Genetic research: The human FLT3 stable cell line is used as a tool for genetic research, particularly in understanding the relationship between certain genes and different forms of leukemia.
Protein interaction studies: These cells can be used for protein-protein interaction studies to gain insight into the FLT3 signaling pathway.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
Robust and stable expression of FLT3 in these cells is critical for our targeted drug development programs. We have successfully used this cell line to identify several promising FLT3 inhibitors, which has greatly accelerated our research progress.
This cell line exhibits excellent survival and proliferation rates, which are critical for our high-throughput screening assays. This allows us to perform multiple parallel tests without the common problem of cell line degradation affecting our results.
We have been using the Human FLT3 Stable Cell Line-Ba/F3 for several months in our oncology research lab and the consistency of the results has been remarkable. Each batch performs exactly the same as the previous one, which greatly increases the reliability of our experiments.
Write a review of your use of Biogene products and services in your research. Your review can help your fellow researchers make informed purchasing decisions.